US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

238.79

+1.340.56%

Volume:7K

Turnover:1.68M

Market Cap:479.13M

PE:- -

High:238.79

Open:237.30

Low:236.64

Close:237.45

52wk High:246.55

52wk Low:171.63

Shares:2.01M

Float Shares:2.01M

Volume Ratio:1.19

T/O Rate:0.35%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Gilead put volume heavy and directionally bearish

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BBH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":238.79,"timestamp":1791219376498,"preClose":237.4531,"halted":0,"volume":7083,"delay":0,"changeRate":0.005630164440893742,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Trading","change":1.3369,"latestTime":"10-05 12:57:42 EDT","open":237.2999,"high":238.79,"low":236.6444,"amount":1684315.58436,"amplitude":0.009036,"askPrice":239.12,"askSize":300,"bidPrice":238.88,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":237.4531,"sharesOutstanding":1976503,"nav":237.39591,"aum":476335613.78,"dividendRate":0.003978,"bidAskSpread":0.001118,"postHourTrading":{"tag":"盘后","latestPrice":237.58,"preClose":237.4531,"latestTime":"19:30 EDT","volume":23,"amount":5462.9441,"timestamp":1790983804584,"change":0.1269,"changeRate":0.000534,"amplitude":0},"volumeRatio":1.188125,"impliedVol":0.196,"impliedVolPercentile":0.4701},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.188125,"shares":2006503,"dividePrice":0.9498,"high":238.79,"amplitude":0.009036,"preClose":237.4531,"low":236.6444,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":238.79,"committee":-0.2,"eps":0,"divideRate":0.003978,"volume":7083,"delay":0,"ttmEps":0,"open":237.2999,"prevYearClose":189.2649,"prevWeekClose":237.4531,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":245.3373,"twentyDayClose":241.1222,"sixtyDayClose":205.546},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672758407","title":"Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672758407","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672758407?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:09","pubTimestamp":1790842140,"startTime":"0","endTime":"0","summary":"0809 GMT - Sanofi's expanded alliance with Regeneron Pharmaceuticals represents the French drugmaker's first step toward addressing its long-term outlook and should be seen as a clear sign of progress under new CEO Belen Garijo, Jefferies analysts write in a research note. \"While the assets are early-stage, the expansion should be viewed positively, as it signals the new CEO's proactive focus on the most important yet addressable uncertainties investors face, as well as the speed of progress,\" the analysts say. Potential acquisitions and a settlement to delay the arrival of copycat versions of the alliance's blockbuster drug Dupixent are other key steps Sanofi needs to take to address the sales hole left by that medicine's patent expiration between 2031 and 2032, the analysts add. Sanofi shares rise 0.6%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0882574055.USD","BK4585","TBXU","LU0823434583.USD","LU2362541513.USD","BK4588","LU0823434740.USD","LU1974910355.USD","IBB","SNY","LU2468319806.SGD","LU0114720955.EUR","LU2089984988.USD","LU0823416689.USD","LU2362541273.HKD","BBH","LU2324357040.USD","LU2362540622.SGD","LU0889565916.HKD","LU0289739699.SGD","LU2023250504.SGD","LU2106854487.HKD","LU0053666078.USD","SNYNF","LU0109394709.USD","IE00BFXG1179.USD","LU0320765992.SGD","BK4139","LU0058720904.USD","REGN","IBBQ","LU1917777945.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672073056","title":"Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672073056","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672073056?lang=en_us&edition=fundamental","pubTime":"2026-10-01 15:10","pubTimestamp":1790838600,"startTime":"0","endTime":"0","summary":"0709 GMT - Sanofi's deal to expand its alliance with U.S. peer Regeneron Pharmaceutical provides a boost to the French company's early-stage drug pipeline, J.P. Morgan analysts write in a research note. The conclusion of the negotiations with Regeneron is positive for Sanofi, the analysts say. Sanofi will pay Regeneron $1 billion upfront, and up to $7 billion subject to certain targets to get access to four new drug candidates invented by its partner. Now that an agreement with Regeneron has been reached, Sanofi investors are likely to switch their focus to the company's moves to strengthen its business through dealmaking, the analysts say. Sanofi shares rise 2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0889565916.HKD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","LU1974910355.USD","SNYNF","LU2089984988.USD","LU2106854487.HKD","BK4007","SNY","LU2324357040.USD","TBXU","IBB","LU2362541513.USD","IE00BFXG1179.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734089","title":"Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734089","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734089?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:40","pubTimestamp":1790833252,"startTime":"0","endTime":"0","summary":"UPDATE 4-Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal disputeOct 1 (Reuters)-SanofiSASY.PAand RegeneronREGN.Osaid on Thursday they will develop four new drugs to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL6N45N09P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","IBBQ","TBXU","LU0889565916.HKD","LU0823416689.USD","LU0320765992.SGD","BBH","LU0109394709.USD","LU2106854487.HKD","LU1974910355.USD","LU2362541513.USD","REGN","LU0882574055.USD","LU0058720904.USD","IBB","BK4585","LU2089984988.USD","LU2468319806.SGD","LU0823434740.USD","LU2023250504.SGD","BK4588","LU2362540622.SGD","LU0289739699.SGD","LU0053666078.USD","BK4139","LU0823434583.USD","LU1917777945.USD","LU2237438978.USD","LU2362541273.HKD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734581","title":"Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734581","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734581?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830918,"startTime":"0","endTime":"0","summary":"Regeneron, Sanofi expand antibody alliance with USD 1 billion upfront paymentRegeneron expanded its immunology alliance with Sanofi to co-develop and co-commercialize four next-generation, long-acting","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL5hDHkz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4112","SG9999014039.USD","LU2324357040.USD","LU0823434583.USD","LU0058720904.USD","LU2362540622.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU1917777945.USD","LU0320765992.SGD","LU0109394709.USD","IE00BN0W2W23.USD","IBB","IE00BGHQF748.EUR","BK4139","LU2362541273.HKD","LU2468319806.SGD","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","TBXU","SG9999014021.USD","LU0053666078.USD","LU2089984988.USD","LU0114720955.EUR","IBBQ","NDAQ","IE00BN0W2V16.EUR","LU1974910355.USD","LU2210149790.SGD","LU0289739699.SGD","LU2106854487.HKD","SG9999014005.SGD","LU2362541513.USD","BK4588","LU0823434740.USD","LU0882574055.USD","IE00BQXX3F31.USD","LU2095319765.USD","LU0823416689.USD","BCDF","BK4585","BBH","REGN","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","LU2237438978.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672533734","title":"Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2672533734","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672533734?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830877,"startTime":"0","endTime":"0","summary":"Sanofi, Regeneron expand antibody alliance in long-acting immunology programs for USD 1 billion upfrontSanofi expanded its global antibody alliance with Regeneron to add four next-generation, long-act","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLbTWmXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2095319765.USD","LU2362540622.SGD","LU0889565916.HKD","LU2362541273.HKD","BBH","BK4139","SG9999014039.USD","LU0320765992.SGD","IE00BQXX3D17.EUR","LU2210149790.SGD","LU0053666078.USD","LU0058720904.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","LU0882574055.USD","BK4112","IE00B3QW5Z07.USD","LU1974910355.USD","LU2089984988.USD","BCDF","LU2106854487.HKD","IE00B64PRP62.GBP","LU2324357040.USD","SG9999014021.USD","TBXU","IBB","LU2362541513.USD","IBBQ","NDAQ","LU0823416689.USD","IE00BN0W2T93.GBP","BK4588","LU1917777945.USD","BK4585","LU0314104364.USD","LU2023250504.SGD","LU0289739699.SGD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","LU0109394709.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734593","title":"Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734593","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734593?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830810,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N05O:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU1974910355.USD","BBH","LU2468319806.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0823434583.USD","BK4585","BK4588","REGN","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","LU0823434740.USD","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU2324357040.USD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573435","title":"Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573435?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N05O:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0889565916.HKD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","LU2324357040.USD","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672343697","title":"Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672343697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672343697?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N05O:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BBH","IBBQ","LU2023250504.SGD","BK4139","IBB","BK4588","LU0823434583.USD","LU0823434740.USD","TBXU","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0114720955.EUR","LU2362541513.USD","LU0058720904.USD","LU2362541273.HKD","LU0882574055.USD","LU1974910355.USD","REGN","LU0823416689.USD","LU2237438978.USD","LU2089984988.USD","LU0289739699.SGD","LU2362540622.SGD","LU2468319806.SGD","LU2106854487.HKD","LU1917777945.USD","LU2324357040.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734350","title":"Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734350?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830808,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1B3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","LU2324357040.USD","LU0889565916.HKD","BK4585","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","IBB","LU0053666078.USD","LU0109394709.USD","IBBQ","BK4588","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273391","title":"The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273391?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:00","pubTimestamp":1790812800,"startTime":"0","endTime":"0","summary":"For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose?Now it is changing to: What kind of weight are they losing?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU0354030438.USD","BK4139","LU1623119135.USD","LU2089984988.USD","ILDR","IHE","IBB","BK4534","IE00BJT1NW94.SGD","LU2237443978.SGD","MHIP","PPH","IE00BK4W5M84.HKD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2462157665.USD","LU0683600562.USD","LU2462591350.SGD","LU1691799644.USD","LU1720051108.HKD","ELIS","LU0234572021.USD","LU1868836591.USD","BBH","LU0889565916.HKD","MEDX","LU2756315318.SGD","LU0174119429.USD","LU0320765992.SGD","LU2106854487.HKD","SGXZ51526630.SGD","LU2361044949.HKD","LU0061475181.USD","LU2213496289.HKD","CURE","IE00BKPKM429.USD","LLII","LU1814569148.SGD","NVOC","SG9999015986.USD","IYH","LU0385154629.USD","LU0640476718.USD","LU2112291526.USD","SG9999014880.SGD","LU2089284900.SGD","IE00B7KXQ091.USD","SG9999018865.SGD","LU0122379950.USD","BK4533","LU0114720955.EUR","LU2211815571.USD","LU2089283258.USD","LLY","LU1804176565.USD","LU2491050071.SGD","OZEM","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0353189763.USD","BK4588","LU0882574055.USD","LU1720051017.SGD","IE00BJJMRY28.SGD","LU0109391861.USD","IXJ","WDNA","LU0820561818.USD","LU2471134952.CNY","BK4599","LU1064131342.USD","LU1983299246.USD","LU2491050154.USD","LU2756315664.SGD","IBBQ","LU0256863902.USD","LU0672654240.SGD","LU0210536198.USD","LU1267930730.SGD","LU2471134796.USD","LU2552382058.USD","LU1868836757.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU1366192091.USD","LU0787776722.HKD","LU2168564065.EUR","LU1712237335.SGD","LU0323591593.USD","LU2602419157.SGD","LU0096364046.USD","LLYX","LU0289739699.SGD","LU0097036916.USD","LU0345770993.USD","LU0345770308.USD","LU0353189680.USD","LU0256863811.USD","LLYZ","LU1023059063.AUD","LU1093756325.SGD","BK4516","BK4585","LU0058720904.USD","LU0198837287.USD","LU0432979614.USD","LU2237443382.USD","LU2362541513.USD","SG9999001176.USD","LU2237443465.HKD","LU0154236417.USD","LU0689472784.USD","LU2471134523.USD","BK4532","IE0004445015.USD","LU0823434583.USD","LU0823434740.USD","LU2111349929.HKD","LU0238689110.USD","LU2168564149.EUR","SGXZ99366536.SGD","LU0320765059.SGD","LU0964807845.USD","LU2237438978.USD","LU2746668461.USD","LU2552382215.SGD","CANC","LU0109394709.USD","IE00B2B36J28.USD","LU1323610961.USD","LU2361045086.USD","SGXZ81514606.USD","TMED","LU2023251221.USD","LU0820561909.HKD","SG9999014898.SGD","LU0417517546.SGD","LU0053666078.USD","VHT","LU2028103732.USD","AGNG","LU1061106388.HKD","SG9999001176.SGD","FHLC","TRUH","NVOH","LU0158827948.USD","ELIL","LU0158827781.USD","LU2237443622.USD","LU2362541273.HKD","LU1629891620.HKD","LU2108987350.USD","NVOX","LU0943347566.SGD","LU2468319806.SGD","IE00BN29S564.USD","IE00BZ1G4Q59.USD","LU2271345857.HKD","LU2063271972.USD","LU2361044865.SGD","HRTS","LU2362540622.SGD","SG9999015952.SGD","SG9999017495.SGD","IE00B1XK9C88.USD","SG9999014906.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU2552382132.HKD","LU0316494557.USD","LU2023250504.SGD","NVO","REGN","IE00B4JS1V06.HKD","IE0002141913.USD","PJP","LU0471298694.HKD","LU1127390331.HKD","IE0009355771.USD","LU1280957306.USD","LU1035775433.USD","SG9999015978.USD","LU2023250330.USD","TBXU","IE0001KFT4U8.USD","IE0005OL40V9.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0823416689.USD","LU1057294990.SGD","SG9999018857.SGD","LU1868836914.USD","LU1979441026.SGD","LU2746668974.SGD","LU1988902786.USD","LU1989771016.USD","IE00B775H168.HKD","GDOC","LU0471298777.SGD","LU1145028129.USD","LU1868837136.USD","XLV","LU1093756168.USD","SG9999014914.USD","LU2750360997.AUD","LU2168563687.JPY","LU1548497426.USD","LU0786609619.USD","IE0004445239.USD","LU1917777945.USD","LU0203202063.USD","LU0354030511.USD","LU1069344957.HKD","LU1291159041.SGD","LU0094547139.USD","LU2237443549.SGD","LU0882574139.USD","SG9999015945.SGD","LU2417539215.USD","LU2750360641.GBP","IE00BKVL7J92.USD","BK4581","LU0466842654.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU2087625088.SGD","LU2168564495.EUR","JDOC","LU2265009873.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","BK4007","LU2324357040.USD","RXL","LU0079474960.USD","LU2360106947.USD","IE00BFSS8Q28.SGD","LU2896262040.SGD","IE00BKDWB100.SGD","LU0203201768.USD","LU0006306889.USD","LU2236285917.USD","LU0820562030.AUD","LU2471134879.HKD","IE00BWXC8680.SGD","LU1974910355.USD","LU0225283273.USD","THNR","LU1232071149.USD","LU2357305700.SGD","LU2237443895.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0708995401.HKD","LU2264538146.SGD","FTXH","LU2168564222.USD","MEDI","LU0133085943.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672809747","title":"Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672809747","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672809747?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:01","pubTimestamp":1790805660,"startTime":"0","endTime":"0","summary":"Regeneron drug halves muscle loss in combination with Novo's semaglutide in trialSept 30 (Reuters)-An experimental weight-loss drug being developed by RegeneronREGN.Oused in combination with Novo Nord","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45L14A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","TBXU","LU2324357040.USD","LU2362541273.HKD","LU0114720955.EUR","LU0823416689.USD","LU0320765992.SGD","IBBQ","LU2362540622.SGD","LU2468319806.SGD","LU0289739699.SGD","BBH","BK4585","LU0058720904.USD","BK4588","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD","BK4139","LU0823434583.USD","REGN","LU0109394709.USD","LU1917777945.USD","IBB","LU2089984988.USD","LU0823434740.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672774782","title":"Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672774782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672774782?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:35","pubTimestamp":1790800500,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.47% to $149.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 5.24% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Abbott Laboratories  fell 2.10% to $98.83.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1023059063.AUD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1585245621.USD","LU2468319806.SGD","BK4578","IBBQ","LU2089984988.USD","BK4583","TMED","GILD","LU0965508806.USD","BIB","MEDI","BK4550","LU1057294990.SGD","LU0861579265.USD","LU0965509283.SGD","LU0234570918.USD","LU1674673428.USD","LU1934455277.USD","LU2324357040.USD","LU1066053197.SGD","BK4585","LU2087621335.USD","SG9999015986.USD","LU0965509101.SGD","BK4532","IE00BSNM7G36.USD","LU1037948897.HKD","SG9999015945.SGD","LU1778281490.HKD","LU1061106388.HKD","LU0289739699.SGD","BBH","LU2357627491.SGD","LU0114720955.EUR","LU0122379950.USD","TBXU","LU0859254822.USD","IBB","IE00B19Z3581.USD","IE0002270589.USD","IE00B3T34201.USD","LU0109394709.USD","LU0889565916.HKD","LU2112291526.USD","LU0965509010.AUD","BK4139","LU0823416689.USD","LU1037948541.HKD","LU1839511570.USD","LU1934455863.HKD","LU1066051498.USD","IE00BKVL7J92.USD","LU0882574055.USD","BK4588","LU1571399168.USD","BK4568","LU1674673691.USD","LU1934455194.USD","BK4566","SG9999015952.SGD","IE00B7SZLL34.SGD","LU0320765992.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672278203","title":"Moderna Inc. Stock Sheds 5.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672278203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672278203?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:33","pubTimestamp":1790800380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 5.4% to $192.57 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.Moderna Inc. closed 7.8% short of its 52-week high of $208.90, which the company reached on September 29th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Pfizer Inc. fell 0.7% to $28.52, and Gilead Sciences Inc. fell 1.47% to $149.05.Trading volume totaled 20.1 million, compared to the 50-day average of 19.4 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","SG9999015952.SGD","IBB","BK4533","IE00BZ1G4Q59.USD","LU1674673691.USD","GNOM","BMED","BK4566","LU0289739699.SGD","LU1066051498.USD","TMED","LU1066053197.SGD","BK4532","LU2089984988.USD","LU2357627491.SGD","IE0002270589.USD","LU0109394709.USD","LU1778281490.HKD","BK4583","MEDI","LU1057294990.SGD","MRNY","BK4585","BK4139","LU1037948897.HKD","LU0320765992.SGD","IDNA","LU1934455194.USD","GILD","BK4534","LU0058720904.USD","LGHT","MRNX","IE00BSNM7G36.USD","BIB","WDNA","MRNA","LU1430594728.SGD","BBH","IE00B19Z3B42.SGD","BK4568","BK4550","LU1934455863.HKD","SG9999015986.USD","LU1023059063.AUD","SG9999015945.SGD","TBXU","IBBQ","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672078261","title":"Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2672078261","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672078261?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:14","pubTimestamp":1790799285,"startTime":"0","endTime":"0","summary":"Regeneron links 2026 CEO, CSO PSU awards to FDA filings, approvals and new-product revenue targets through 2035Regeneron set 2026 performance stock units for its CEO and CSO with a 10-year performance","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL6RTPN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU0058720904.USD","LU0823434583.USD","BBH","LU0109394709.USD","REGN","LU2362540622.SGD","LU2023250504.SGD","LU1974910355.USD","LU0823434740.USD","LU0823416689.USD","LU0889565916.HKD","LU2237438978.USD","LU2324357040.USD","LU2362541513.USD","LU2362541273.HKD","BK4588","IBB","BK4585","LU2106854487.HKD","BK4139","TBXU","IBBQ","LU0289739699.SGD","LU1917777945.USD","LU0053666078.USD","LU2468319806.SGD","LU0882574055.USD","LU0320765992.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784566","title":"Gilead put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784566?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:15","pubTimestamp":1790795714,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Gilead (GILD) with 6,354 puts trading, or 4x expected. Most active are Nov-26 140 puts and 10/9 weekly 146 puts, with total v...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BIB","IBB","LU0823416689.USD","LU1778281490.HKD","BBH","LU1057294990.SGD","BK4532","BK4578","IE00BSNM7G36.USD","LU1585245621.USD","LU0859254822.USD","LU0114720955.EUR","BMED","LU1066051498.USD","GILD","LU0122379950.USD","LU1430594728.SGD","LU2468319806.SGD","LU0965509283.SGD","TBXU","BK4588","LU0058720904.USD","TMED","LU0965509010.AUD","BK4583","LU2324357040.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","SG9999015945.SGD","LU0234570918.USD","LU1934455863.HKD","IBBQ","LU0889565916.HKD","IE00B3T34201.USD","LU0320765992.SGD","LU2087621335.USD","BK4550","LU1037948897.HKD","LU2112291526.USD","MEDI","SG9999015952.SGD","BK4585","BK4568","SG9999015986.USD","LU1061106388.HKD","LU1839511570.USD","LU2357627491.SGD","LU0882574055.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786096","title":"Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786096","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786096?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:30","pubTimestamp":1790785810,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, Inc. (REGN) has completed a Phase...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regenerons-aln-f1202-safety-trial-marks-a-quiet-but-important-pipeline-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regenerons-aln-f1202-safety-trial-marks-a-quiet-but-important-pipeline-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU0889565916.HKD","BBH","LU2468319806.SGD","LU0823416689.USD","LU2362541513.USD","LU2089984988.USD","LU0053666078.USD","LU1917777945.USD","LU2237438978.USD","LU1974910355.USD","LU0823434583.USD","LU2362541273.HKD","BK4588","LU0320765992.SGD","BK4585","LU2106854487.HKD","REGN","LU0109394709.USD","ALN","LU0058720904.USD","LU0114720955.EUR","LU0289739699.SGD","IBBQ","LU0823434740.USD","LU0882574055.USD","BK4139","LU2023250504.SGD","LU2362540622.SGD","TBXU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206126","title":"Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206126?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:12","pubTimestamp":1790766720,"startTime":"0","endTime":"0","summary":"Biotech can't generate the revenue that investors expect, says Wall Street firmModerna was the target of a sell recommendation by Citi.After rallying almost seven-fold this year, Citi is now advising ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","BK4548","WDNA","LU2362540622.SGD","LU0823434583.USD","LU0889565916.HKD","ISBC","LU2362541273.HKD","BK4534","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","BK4532","LU0882574055.USD","BK4211","GNOM","LU1974910355.USD","LU2089984988.USD","MRNY","LU2106854487.HKD","LU2324357040.USD","LGHT","BK4568","BK4533","IBB","LU2362541513.USD","TBXU","IBBQ","LU0823416689.USD","MRNA","IDNA","BK4588","MRNX","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","BK4551","BK4501","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274431","title":"Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274431","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671274431?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:31","pubTimestamp":1790757060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rose 2.9% to 5.71 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 24613.27.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 33% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 6.3% and Amgen Inc. remained unchanged.Trading volume totaled 91.4 million shares, compared to the 50-day average of 81.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0122379950.USD","LU2242652126.USD","BK1191","BK4566","IE00BJJMRZ35.SGD","IE00BZ08YS42.EUR","LU2242646821.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4533","BK4139","TBXU","LU2089984988.USD","BK1515","BK4581","LU0889565916.HKD","LU0320765992.SGD","IE00B2B36J28.USD","PJP","LU0289739699.SGD","LU1061106388.HKD","SG9999001440.SGD","BIB","BK1521","LU1571399168.USD","IE00BZ08YR35.GBP","IBB","IE00BZ08YT58.USD","BK4534","LU0868494617.USD","LU1983299246.USD","BK1589","IE00BJT1NW94.SGD","BBH","LU0109394709.USD","BK4599","IE00B4R5TH58.HKD","HK0000165453.HKD","LU2112291526.USD","PBE","01177","LU1057294990.SGD","AMGN","IE0009355771.USD","BK4588","LU2468319806.SGD","LU0058720904.USD","LU1023059063.AUD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671324755","title":"Moderna Inc. Stock Climbs 3.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2671324755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671324755?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:35","pubTimestamp":1790714100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 3.1% to $203.46 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $202.67, which the company achieved on September 25th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.6% to $267.57, Pfizer Inc. remained unchanged, and Gilead Sciences Inc. fell 0.61% to $151.28.Trading volume totaled 13.1 million, compared to the 50-day average of 19.2 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK4578","WDNA","LU0965509283.SGD","LU0882574055.USD","BK4585","LU1057294990.SGD","LU0058720904.USD","TMED","LU1934455194.USD","LGHT","BK4550","LU1430594728.SGD","BK4551","BMED","LU0859254822.USD","LU1674673428.USD","BK4533","LU0965508806.USD","MRNA","LU0861579265.USD","BBH","MRNY","LU1066053197.SGD","GNOM","TBXU","LU0965509010.AUD","IE00B3T34201.USD","LU1934455277.USD","BK4534","LU0889565916.HKD","LU1571399168.USD","LU0320765992.SGD","BK4501","GILD","BIB","LU2468319806.SGD","MEDI","IBB","LU0114720955.EUR","LU1674673691.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU2089984988.USD","IE00BZ1G4Q59.USD","MRNX","LU0122379950.USD","LU2324357040.USD","LU1839511570.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247515","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247515","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247515?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:34","pubTimestamp":1790714040,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.32% to $423.64 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.17% to 7,670.84 and Dow Jones Industrial Average  falling 0.26% to 51,349.92.This was the stock's third consecutive day of gains.Amgen Inc. closed 5.23% below its 52-week high of $447.03, which the company achieved on August 25th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 1.61% to $267.57, Pfizer Inc.  remained unchanged, and AbbVie Inc.  fell 1.12% to $263.29.Trading volume  eclipsed its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU1057294990.SGD","BK4588","BK4581","LU2112291526.USD","BK4139","IE00B2B36J28.USD","BK4599","IE00B4R5TH58.HKD","PJP","LU0109394709.USD","BIB","04332","LU1061106388.HKD","BK4585","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4566","LU0320765992.SGD","BK4533","IE0009355771.USD","LU1571399168.USD","LU2242652126.USD","LU0889565916.HKD","AMGN","IBB","IE0002141913.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","BBH","BK4534","LU0289739699.SGD","LU2242646821.SGD","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","PBE","IBBQ","SG9999001440.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}